Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

BACKGROUND: The association between prior bevacizumab (BEV) therapy and ramucirumab (RAM)-induced proteinuria is not known. We aimed to investigate this association in patients with metastatic colorectal cancer (mCRC). METHODS: mCRC patients who received folinic acid, fluorouracil, and irinotecan (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Dote, Satoshi, Shiwaku, Eiji, Kohno, Emiko, Fujii, Ryohei, Mashimo, Keiji, Morimoto, Naomi, Yoshino, Masaki, Odaira, Naoki, Ikesue, Hiroaki, Hirabatake, Masaki, Takahashi, Katsuyuki, Takahashi, Masaya, Takagi, Mari, Nishiuma, Satoshi, Ito, Kaori, Shimato, Akane, Itakura, Shoji, Takahashi, Yoshitaka, Negoro, Yutaka, Shigemori, Mina, Watanabe, Hiroyuki, Hayasaka, Dai, Nakao, Masahiko, Tasaka, Misaki, Goto, Emi, Kataoka, Noriaki, Yokomizo, Ayako, Kobayashi, Ayako, Nakata, Yoko, Miyake, Mafumi, Hayashi, Yaeko, Yamamoto, Yoshie, Hirata, Taiki, Azuma, Kanako, Makihara, Katsuya, Fukui, Rino, Tokutome, Akira, Yagisawa, Keiji, Honda, Shinji, Meguro, Yuji, Suzuki, Shota, Yamaguchi, Daisuke, Miyata, Hitomi, Kobayashi, Yuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233195/
https://www.ncbi.nlm.nih.gov/pubmed/37261583
http://dx.doi.org/10.1007/s10147-023-02357-3

Ejemplares similares

Ejemplares similares